REQUEST A DEMO
Total
USD $0.00
Search more companies

Anterogen Co.,Ltd. (South Korea)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Anterogen Co.,Ltd. Profile Updated: July 26, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Anterogen Co.,Ltd. is engaged in manufacturing cell therapy products. The company offers Adipocell® used for the treating depressed scar; Queencell® used for regeneration of subcutaneous adipose tissue; and Cupistem® used as injection for treating of Crohn's fistula. Anterogen Co.,Ltd. also offers cosmetic products and cosmetic raw materials including SCM2®, SCM2®-Black, Therastem®-Derma, Therastem®-White Silk, StemCell Media Program Set and SCM (Human Stem cell Conditioned Media). In addition, the company also offers services including Stem cell banking services and analysis services. Anterogen Co.,Ltd. is based in Seoul, South Korea. The company was incorporated in 2000.

Headquarters
405 130 Digital-Ro, Geumcheon-Gu
Seoul; Seoul; Postal Code: 08589

Contact Details: Purchase the Anterogen Co.,Ltd. report to view the information.

Website: http://www.anterogen.com

Basic Information
Total Employees:
Purchase the Anterogen Co.,Ltd. report to view the information.
Outstanding Shares:
Purchase the Anterogen Co.,Ltd. report to view the information.
Registered Capital:
Purchase the Anterogen Co.,Ltd. report to view the information.
Financial Auditors:
Purchase the Anterogen Co.,Ltd. report to view the information.
Incorporation Date:
March 16, 2000
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Outside Director
Purchase this report to view the information.
Auditor
Ownership Details
Purchase this report to view the information.
12.8%
Purchase this report to view the information.
8.1%
Purchase this report to view the information.
6.9%
Subsidiaries
Em-Tech Co.,Ltd.
Company Performance
Financial values in the chart are available after Anterogen Co.,Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency KRW. Absolute financial data is included in the purchased report.
Net sales revenue
5.14%
Total operating revenue
5.36%
Operating profit (EBIT)
45.4%
EBITDA
42.94%
Net Profit (Loss) for the Period
32.6%
Total assets
-11.34%
Total equity
-2.17%
Operating Profit Margin (ROS)
52.9%
Net Profit Margin
18.81%
Return on Equity (ROE)
0.43%
Quick Ratio
39.11%
Cash Ratio
1.28%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?